Drug Type Small molecule drug |
Synonyms DNL-0500 |
Target- |
Mechanism- |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pituitary ACTH Hypersecretion | Preclinical | US | 30 Nov 2022 | |
Pituitary ACTH Hypersecretion | Preclinical | EU | 30 Nov 2022 |